Fund Holdings — First Light Asset Management, LLC

Total Portfolio Value:
$1.12B
Total Bought:
$241.88M
Total Sold:
$375.20M
Net Transaction:
-$133.32M
Notable People:
Mathew Paul Arens
Securities
▲▼
SharesValue
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Axogen, Inc.COMMON STOCKS(AXGN)5,233,3264,002,768-1,230,558$171.29M$132.61M11.88%-$38.68M
Palvella Therapeutics, Inc.COMMON STOCKS(PVLA)709,141980,758+271,617$74.23M$122.25M10.96%+$48.03M
NeoGenomics, Inc.COMMON STOCKS(NEO)10,035,0639,729,978-305,085$118.01M$72.20M6.47%-$45.82M
SI-BONE, Inc.COMMON STOCKS(SIBN)5,032,9045,353,190+320,286$99.25M$67.61M6.06%-$31.64M
Centessa Pharmaceuticals LimitedCOMMON STOCKS2,278,9401,560,991-717,949$57.00M$62.00M5.56%+$5.01M
Apogee Therapeutics IncCOMMON STOCKS284,991576,684+291,693$21.51M$48.54M4.35%+$27.03M
Amylyx Pharmaceuticals, Inc.COMMON STOCKS(AMLX)3,355,5393,190,645-164,894$40.53M$44.35M3.97%+$3.82M
Twist Bioscience CorporationCOMMON STOCKS(TWST)1,140,771878,848-261,923$36.19M$41.76M3.74%+$5.58M
Crinetics Pharmaceuticals IncCOMMON STOCKS1,194,2631,089,670-104,593$55.59M$39.58M3.55%-$16.02M
908 Devices Inc.COMMON STOCKS(MASS)4,836,1866,072,563+1,236,377$25.39M$37.16M3.33%+$11.77M
NeuroPace, Inc.COMMON STOCKS(NPCE)1,349,4822,459,966+1,110,484$20.84M$32.35M2.90%+$11.51M
Edgewise Therapeutics, Inc.COMMON STOCKS(EWTX)1,573,7011,001,846-571,855$39.05M$31.56M2.83%-$7.49M
Anaptys Bio IncCOMMON STOCKS646,238565,431-80,807$31.33M$31.36M2.81%+$29.2K
Simulations Plus IncCOMMON STOCKS1,968,9172,632,823+663,906$35.89M$31.12M2.79%-$4.77M
Guardant Health, Inc.COMMON STOCKS(GH)294,751280,299-14,452$30.11M$25.89M2.32%-$4.21M
Tandem Diabetes Care, Inc.COMMON STOCKS(TNDM)1,089,4931,314,715+225,222$23.95M$25.20M2.26%+$1.26M
AtriCure, Inc.COMMON STOCKS(ATRC)1,175,445729,521-445,924$46.50M$20.81M1.87%-$25.69M
TriSalus Life Sciences, Inc.COMMON STOCKS(TLSI)05,066,827+5,066,827$0$20.27M1.82%+$20.27M
Tectonic Therapeutic, Inc.COMMON STOCKS(TECX)0647,743+647,743$0$20.02M1.79%+$20.02M
iRhythm Holdings, Inc.COMMON STOCKS(IRTC)153,871168,116+14,245$27.30M$19.84M1.78%-$7.46M
Septerna, Inc.COMMON STOCKS(SEPN)620,811732,860+112,049$17.31M$17.61M1.58%+$302.4K
Establishment Labs Holdings Inc.COMMON STOCKS(ESTA)373,082307,738-65,344$27.19M$17.47M1.57%-$9.72M
Health Catalyst, Inc.COMMON STOCKS(HCAT)12,910,94112,878,700-32,241$30.86M$16.36M1.47%-$14.50M
Omnicell, Inc.COMMON STOCKS(OMCL)0489,846+489,846$0$16.35M1.47%+$16.35M
KORU Medical Systems, Inc.COMMON STOCKS(KRMD)4,210,5123,768,380-442,132$24.46M$16.28M1.46%-$8.18M
GeneDx Holdings Corp.COMMON STOCKS(WGS)0242,927+242,927$0$15.60M1.40%+$15.60M
Wave Life Sciences, Inc.COMMON STOCKS(WVE)1,853,8511,843,968-9,883$31.52M$13.37M1.20%-$18.15M
Vera Therapeutics, Inc.COMMON STOCKS(VERA)869,676313,906-555,770$44.04M$12.63M1.13%-$31.41M
MiMedx Group, Inc.COMMON STOCKS(MDXG)3,039,3412,842,892-196,449$20.58M$11.23M1.01%-$9.35M
Butterfly Network, Inc.COMMON STOCKS(BFLY)2,812,1312,660,167-151,964$10.69M$10.75M0.96%+$61.0K
SpyGlass Pharma, Inc.COMMON STOCKS(SGP)0375,000+375,000$0$9.72M0.87%+$9.72M
Organogenesis Holdings Inc.COMMON STOCKS(ORGO)3,862,8203,498,533-364,287$20.01M$8.29M0.74%-$11.72M
Vaxcyte, Inc.COMMON STOCKS(PCVX)0141,784+141,784$0$8.24M0.74%+$8.24M
Enliven Therapeutics IncCOMMON STOCKS0201,867+201,867$0$7.91M0.71%+$7.91M
Rhythm Pharmaceuticals, Inc.COMMON STOCKS(RYTM)295,84487,181-208,663$31.67M$7.58M0.68%-$24.09M
ABIVAX Société AnonymeCOMMON STOCKS(ABVX)88,6740-88,674$11.96M$0—-$11.96M
Disc Medicine, Inc.COMMON STOCKS(IRON)523,1670-523,167$41.54M$0—-$41.54M
Dyne Therapeutics, Inc.COMMON STOCKS(DYN)155,2310-155,231$3.04M$0—-$3.04M
Ishares Russell 2000 Growth EtfCOMMON STOCKS7600-760$245.5K$0—-$245.5K
Madrigal Pharmaceuticals, Inc.COMMON STOCKS(MDGL)66,8310-66,831$38.92M$0—-$38.92M
Page 1 of 1
First Light Asset Management, LLC — 13F Holdings — Q1 2026 | TickerTrail